Regarding other candidate genes, such as HAMP and CAV1, although numerous studies have demonstrated their potential roles in RCC and their adverse effects on the prognosis of ccRCC patients [19, 20], their impact on the malignant phenotype of renal cancer cells in our in vitro model was not significant. This evidence concerns the gene HAMP and nonpapillary renal cell carcinoma.